Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

77 Stocks Moving In Tuesday's Mid-Day Session

Published 10/05/2022, 17:00
Updated 10/05/2022, 17:41
© Reuters.  77 Stocks Moving In Tuesday's Mid-Day Session

Gainers

  • Biohaven Pharmaceutical Holding Company Ltd. (NASDAQ: BHVN) shares jumped 70.8% to $142.01. Pfizer Inc (NYSE: NYSE:PFE) will acquire Biohaven Pharmaceutical Holding for $148.50 per share, equivalent to $11.6 billion.
  • Vroom, Inc. (NASDAQ: VRM) shares gained 38.4% to $1.4950 after the company reported better-than-expected Q1 results.
  • Appian Corporation (NASDAQ: APPN) gained 34.5% to $57.86. Appian was awarded $2.036 billion in damages against Pegasystems Inc..
  • AdaptHealth Corp. (NASDAQ: AHCO) shares climbed 25.9% to $14.39 after the company reported upbeat Q1 sales and announced a $200 million buyback.
  • CECO Environmental Corp. (NASDAQ: CECE) gained 24.7% to $5.30 after the company posted upbeat Q1 results and announced the purchase of Compass Water Solutions.
  • Assertio Holdings, Inc. (NASDAQ: ASRT) rose 23.1% to $2.3150 after the company reported better-than-expected Q1 EPS and sales results.
  • Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) gained 22.2% to $10.93 following strong quarterly sales.
  • ShockWave Medical, Inc. (NASDAQ: SWAV) jumped 21.1% to $140.38 after the company reported better-than-expected Q1 results and raised its FY22 sales guidance to above analyst estimates.
  • FibroGen, Inc. (NASDAQ: FGEN) gained 20.2% to $9.55 after the company reported better-than-expected Q1 EPS results.
  • The Pennant Group, Inc. (NASDAQ: PNTG) jumped 19.7% to $15.32 following strong quarterly results.
  • Myovant Sciences Ltd. (NYSE: MYOV) gained 19% to $9.26 following Q4 earnings.
  • Intra-Cellular Therapies, Inc. (NASDAQ: ITCI) gained 18.6% to $50.97 after reporting narrower-than-expected quarterly loss.
  • Angi Inc. (NASDAQ: ANGI) jumped 18% to $4.2350 following upbeat quarterly sales.
  • Cyngn Inc. (NASDAQ: CYN) gained 17.8% to $5.01.
  • Cara Therapeutics, Inc. (NASDAQ: CARA) gained 17.7% to $8.77 after reporting upbeat quarterly results.
  • Y-mAbs Therapeutics, Inc. (NASDAQ: YMAB) jumped 16.8% to $9.61 following narrower-than-expected quarterly loss.
  • Park-Ohio Holdings Corp. (NASDAQ: PKOH) gained 16.6% to $11.50 after the company reported better-than-expected Q1 sales results and EPS results were higher year over year.
  • Haemonetics Corporation (NYSE: HAE) gained 16.5% to $57.41 following better-than-expected quarterly results.
  • Nuvation Bio Inc. (NYSE: NUVB) jumped 16.1% to $4.91 after the company posted a narrower quarterly loss.
  • Cronos Group Inc. (NASDAQ: CRON) rose 14.4% to $3.24 following Q1 results.
  • Cortexyme, Inc. (NASDAQ: CRTX) gained 14% to $3.74. Cortexyme agreed to acquire privately held Novosteo, which is focused on targeted therapeutics to treat rare skeletal diseases, bone cancer and injury.
  • Coupang, Inc. (NYSE: CPNG) jumped 13.3% to $10.60.
  • OPKO Health, Inc. (NASDAQ: OPK) jumped 12.7% to $2.75 following Q1 results.
  • Seagen Inc. (NASDAQ: SGEN) gained 12.2% to $122.25. The Board of Directors of Seagen announced that its long-time president, CEO, and chairman Clay Siegall, is on a leave of absence.
  • Color Star Technology Co., Ltd. (NASDAQ: CSCW) rose 12.1% to $0.1278 after dropping 12% on Monday.
  • Nutex Health, Inc. (NASDAQ: NUTX) rose 11.4% to $5.18 after declining 22% on Monday.
  • LivePerson, Inc. (NASDAQ: LPSN) rose 10.9% to $18.08 following Q1 results.
  • NeuroBo Pharmaceuticals, Inc. (NASDAQ: NRBO) rose 9.5% to $0.5113 after tumbling 23% on Monday.
  • Evolve Transition Infrastructure LP (NYSE: SNMP) rose 7.8% to $0.4398 after declining around 7% on Monday.
  • Cenntro Electric Group Limited (NASDAQ: CENN) rose 7.1% to $1.5850. Nuvve Holding Corp. and Cenntro reported an alliance to accelerate adoption of commercial electric vehicles.
  • Clover Health Investments, Corp. (NASDAQ: CLOV) rose 5.4% to $2.54 after the company reported better-than-expected Q1 sales results and reaffirmed its FY22 guidance.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Losers

  • Upstart (NASDAQ:UPST) Holdings, Inc. (NASDAQ: UPST) shares dipped 56.7% to $33.38 after the company reported Q1 earnings results and issued Q2 and FY22 sales guidance below analyst estimates.
  • Kaleyra, Inc. (NYSE: KLR) dipped 38.8% to $3.7250 after the company reported worse-than-expected Q1 EPS and sales results and issued Q2 and FY22 sales guidance below analyst estimates.
  • United Insurance Holdings Corp. (NASDAQ: UIHC) fell 38.5% to $1.3770 after the company reported a wider Q1 core loss.
  • Embark Technology, Inc. (NASDAQ: EMBK) dropped 37.8% to $2.1696.
  • Cipher Mining Inc. (NASDAQ: CIFR) fell 36.2% to $2.06. Cipher Mining posted a Q1 loss of $0.07 per share.
  • Desktop Metal, Inc. (NYSE: DM) dropped 35.3% to $2.2101 following wider-than-expected quarterly loss.
  • Akanda Corp. (NASDAQ: AKAN) dipped 28% to $1.6291.
  • FutureFuel Corp. (NYSE: FF) fell 28.7% to $7.04 after the company said Q1 EPS results were lower year over year.
  • Diebold Nixdorf, Incorporated (NYSE: DBD) fell 28% to $2.7350 after the company posted downbeat quarterly results and lowered sales guidance.
  • Enochian Biosciences, Inc. (NASDAQ: ENOB) fell 27.8% to $4.65.
  • Tenon Medical, Inc. (NASDAQ: TNON) fell 26.8% to $36.42.
  • Bausch Health Companies Inc. (NYSE: BHC) fell 26.4% to $9.49 after the company reported Q1 sales results were down year over year and cut FY22 guidance.
  • Huadi International Group Co., Ltd. (NASDAQ: HUDI) dipped 26.4% to $21.20.
  • GoodRx Holdings, Inc. (NASDAQ: GDRX) shares fell 25.7% to $7.99 after the company Q1 earnings results and issued Q2 sales guidance below analyst estimates.
  • National Vision Holdings, Inc. (NASDAQ: EYE) dropped 25.4% to $25.04 as the company lowered FY22 guidance.
  • FTC Solar, Inc. (NASDAQ: FTCI) fell 24.9% to $2.4699 following downbeat quarterly results.
  • CarGurus, Inc. (NASDAQ: CARG) fell 24.4% to $22.56 after the company reported Q1 earnings results and issued Q2 adjusted EPS guidance below analyst estimates.
  • Spark Networks SE (NASDAQ: LOV) dipped 20.7% to $1.64 following Q1 results.
  • loanDepot, Inc. (NYSE: LDI) dropped 20.3% to $2.15 as the company swung to a loss in the first quarter.
  • Cvent Holding Corp. (NASDAQ: CVT) fell 19.6% to $4.3050 following Q1 results.
  • AppFolio, Inc. (NASDAQ: APPF) dipped 18.8% to $80.99 after reporting a loss for the first quarter.
  • Infrastructure and Energy Alternatives, Inc. (NASDAQ: IEA) dropped 18.3% to $7.01 following wider-than-expected quarterly loss.
  • LogicBio Therapeutics, Inc. (NASDAQ: LOGC) fell 17.8% to $0.5487. LogicBio Therapeutics shares jumped over 34% on Monday after the company announced the FDA lifted the clinical hold on its LB-001 Investigational New Drug Application, allowing patient enrollment to resume in the Phase 1/2 SUNRISE trial for pediatric patients with methylmalonic acidemia.
  • StarTek, Inc. (NYSE: SRT) declined 17.2% to $3.3350 following Q1 results.
  • TaskUs, Inc. (NASDAQ: TASK) dropped 16.4% to $19.50 following Q1 results.
  • Wejo Group Limited (NASDAQ: WEJO) declined 16.2% to $2.18.
  • Babcock & Wilcox Enterprises, Inc. (NYSE: BW) fell 16% to $5.96 following wider-than-expected quarterly loss.
  • FreightCar America, Inc. (NASDAQ: RAIL) dropped 15.4% to $4.29 after reporting Q1 loss.
  • Village Farms International, Inc. (NASDAQ: VFF) dipped 15.1% to $3.26 following weak quarterly results.
  • Benson Hill, Inc. (NYSE: BHIL) fell 14.6% to $2.4550.
  • Local Bounti Corporation (NYSE: LOCL) declined 14.5% to $4.40 following Q1 results.
  • Lightwave Logic, Inc. (NASDAQ: LWLG) fell 14.4% to $8.02.
  • Eve Holding Inc. (NYSE: EVEX) dropped 14.3% to $9.70. Eve Holding reported that its common stock will begin trading on NYSE today under the symbol 'EVEX.'
  • Science 37 Holdings, Inc. (NASDAQ: SNCE) dropped 14% to $3.19. Science 37 Holdings reported better-than-expected Q1 EPS and sales results.
  • Starry Group Holdings, Inc. (NYSE: STRY) fell 14% to $7.22.
  • Dave Inc. (NASDAQ: DAVE) dipped 13.3% to $2.29.
  • Vivid Seats Inc. (NASDAQ: SEAT) dropped 12.7% to $7.52 following Q1 results.
  • Veeco Instruments Inc. (NASDAQ: VECO) fell 11.8% to $20.08 after the company issued weak earnings forecast.
  • Matrix Service Company (NASDAQ: MTRX) dropped 11.6% to $5.74 following wider Q3 loss.
  • TrueCar, Inc. (NASDAQ: TRUE) fell 11.5% to $3.13. TrueCar posted a Q1 net loss of $12.4 million.
  • Aterian, Inc. (NASDAQ: ATER) shares fell 11.5% to $3.5301 after the company reported worse-than-expected Q1 sales results.
  • Affirm Holdings, Inc. (NASDAQ: AFRM) fell 11.4% to $18.25 after Upstart reported financial results and issued guidance below analyst estimates.
  • Revlon, Inc. (NYSE: REV) fell 11.4% to $4.5093. Revlon recently posted a Q1 loss of $1.14 per share.
  • Groupon, Inc. (NASDAQ: GRPN) fell 10.6% to $13.99 after the company reported weaker-than-expected results for its first quarter and issued weak FY22 sales guidance.
  • Novavax, Inc. (NASDAQ: NVAX) fell 9.5% to $48.19 as the company posted downbeat results for its first quarter on Monday.
  • Blue Water Vaccines, Inc. (NASDAQ: BWV) fell 7.8% to $4.9999 after jumping 44% on Monday.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read at Benzinga

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.